Clinical Trials Logo

Malignant Neoplasm of the Breast clinical trials

View clinical trials related to Malignant Neoplasm of the Breast.

Filter by:
  • None
  • Page 1

NCT ID: NCT03777852 Not yet recruiting - Clinical trials for Malignant Neoplasm of the Breast

Emotional Evaluation and Reconstructed Breast Satisfaction

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Data from the National Cancer Institute (Inca) reveal that breast cancer is the most common type of cancer among women worldwide. In Brazil, it is second only to non-melanoma skin cancer. Breast cancer is a feared disease in the female universe because it is considered one of the major causes of death due to neoplasia among women. It brings also the stigma of suffering, mutilation, loss of female identity and loss of body contour. Among other issues, problems with body self-image may have an impact on sexuality and fertility, and also, the incapacity to breastfeed. Breast reconstruction can restore the patient's shape and physical integrity, among other benefits. The research justifies itself because information about the satisfaction of breast reconstruction can be achieved. It is also known that women having breast reconstruction after a mastectomy due to cancer have a favorable evolution. This study will analyze body contour satisfaction of women undergoing mastectomy and breast reconstruction as part of their breast cancer treatment. The Breast Q questionnaire will be used to measure patients satisfaction.

NCT ID: NCT01372917 Completed - Clinical trials for Malignant Neoplasm of the Breast

Evaluating AlloMax in Immediate Expander-Based Breast Reconstruction Study

Start date: January 2010
Phase: N/A
Study type: Observational

The study is a prospective multi-centered cohort study designed to determine the safety and efficacy of AlloMax in immediate expander-based breast reconstruction. Specifically, the study is designed to determine if sterility of human acellular dermal matrix results in a lower incidence of infection and seroma. The study will determine if gamma radiation, as a method of terminally sterilizing human acellular dermal matrix, has a negative impact on graft incorporation into the host tissue.